These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2223436)

  • 21. [Bone biopsy in renal osteodystrophy].
    Serrano S; Mariñoso ML
    Med Clin (Barc); 1991 Apr; 96(15):573-4. PubMed ID: 2051814
    [No Abstract]   [Full Text] [Related]  

  • 22. [Fine structure of mast cells in iliac crest biopsies during renal osteodystrophy].
    Rebel A; Malkani K
    Pathol Biol (Paris); 1974 Mar; 22(3):221-8. PubMed ID: 4603545
    [No Abstract]   [Full Text] [Related]  

  • 23. The efficacy of vitamin D2 and oral phosphorus therapy in X-linked hypophosphatemic rickets and osteomalacia.
    Lyles KW; Harrelson JM; Drezner MK
    J Clin Endocrinol Metab; 1982 Feb; 54(2):307-15. PubMed ID: 6976353
    [No Abstract]   [Full Text] [Related]  

  • 24. [The vitamin D-"hormones". Recent findings on metabolism and therapy].
    Dambacher MA; Girard J; Haas HG
    Internist (Berl); 1972 Apr; 13(4):125-32. PubMed ID: 4555565
    [No Abstract]   [Full Text] [Related]  

  • 25. Rickets, osteomalacia, and renal osteodystrophy. Part II.
    Mankin HJ
    J Bone Joint Surg Am; 1974 Mar; 56(2):352-86. PubMed ID: 4217798
    [No Abstract]   [Full Text] [Related]  

  • 26. The possible use of bisphosphonates in the treatment of renal osteodystrophy.
    Malluche HH
    Clin Nephrol; 1992; 38 Suppl 1():S87-91. PubMed ID: 1295713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D dependent rickets: decreased sensitivity to 1,25-dihydroxyvitamin D.
    Kudoh T; Kumagai T; Uetsuji N; Tsugawa S; Oyanagi K; Chiba Y; Minami R; Nakao T
    Eur J Pediatr; 1981 Nov; 137(3):307-11. PubMed ID: 7318845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [HYPOPHOSPHATASIA].
    GROSSMANN I; GROSSMANN P
    Radiol Diagn (Berl); 1963; 63():139-52. PubMed ID: 14050441
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of rickets and osteomalacia.
    Parfitt AM; Frame B
    Semin Drug Treat; 1972; 2(1):83-115. PubMed ID: 4558760
    [No Abstract]   [Full Text] [Related]  

  • 30. Familial vitamin D deficient osteomalacia and renal osteodystrophy: shaping up the debate.
    Jabur WL
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):128-30. PubMed ID: 20061707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone biopsy studies in the diagnosis and treatment of renal osteodystrophy.
    Sebert JL; Fardellone P; Noel C; Cohen-Solal M; Bellony R; Marie A; Fournier A
    Contrib Nephrol; 1988; 64():49-57. PubMed ID: 3180824
    [No Abstract]   [Full Text] [Related]  

  • 32. [INTRODUCTION TO THE STUDY OF THE PATHOLOGY OF INTESTINAL ABSORPTION OF CALCIUM].
    CANIGGIA A; GENNARI C
    Minerva Med; 1964 Nov; 55():3765-82. PubMed ID: 14241932
    [No Abstract]   [Full Text] [Related]  

  • 33. Disorders of mineral metabolism in the newborn.
    Tuchman S
    Curr Pediatr Rev; 2014; 10(2):133-41. PubMed ID: 25088267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aluminum: culprit or accessory in the genesis of renal osteodystrophy.
    Quarles LD; Gitelman HJ; Drezner MK
    Semin Nephrol; 1986 Mar; 6(1):90-101. PubMed ID: 3299578
    [No Abstract]   [Full Text] [Related]  

  • 35. Advances in endocrine pharmacotherapeutics. Part--III.
    Ahuja MM; Sharma GP; Shivgnanasundaram D
    J Assoc Physicians India; 1984 Nov; 32(11):977-85. PubMed ID: 6151946
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment with 1-alpha hydroxy vitamin D3 of bone disease in hemodialysis. Therapeutic results and complications].
    García de Vinuesa S; Barril G; Luño J; Alles A; Jofré R; Pérez García R; Olivas E; López Gómez JM; Valderrábano F
    Rev Clin Esp; 1980 Dec; 159(5):317-22. PubMed ID: 7221095
    [No Abstract]   [Full Text] [Related]  

  • 37. The action of 1,25 (OH)2D3 on turnover kinetic, remodelling surfaces and structure of trabecular bone in chronic renal failure.
    Delling G; Lühmann H; Bulla M; Fuchs C; Henning HV; Jansen JL; Kohnle W; Schulz W
    Contrib Nephrol; 1980; 18():105-21. PubMed ID: 7353369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathophysiology and treatment of uremic bone disease.
    Coburn J; Kanis J; Popovtzer M; Ritz E; Slatopolsky E; Fleisch H
    Calcif Tissue Int; 1983 Sep; 35(6):712-4. PubMed ID: 6652544
    [No Abstract]   [Full Text] [Related]  

  • 39. Uremic osteodystrophy.
    Prat J; Osborne RL
    Clin Bull; 1976; 6(3):121-4. PubMed ID: 1000788
    [No Abstract]   [Full Text] [Related]  

  • 40. No effect of APD (amino hydroxypropylidene bisphosphonate) on hypercalcemia in patients with renal osteodystrophy.
    Hené RJ; Visser WJ; Duursma SA; Raymakers JA; de bos Kuil RJ; Dorhout Mees EJ
    Bone; 1990; 11(1):15-20. PubMed ID: 2331426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.